FR2373538A1 - Nouveaux derives de prostane, leur procede de preparation et medicament les contenant - Google Patents

Nouveaux derives de prostane, leur procede de preparation et medicament les contenant

Info

Publication number
FR2373538A1
FR2373538A1 FR7736892A FR7736892A FR2373538A1 FR 2373538 A1 FR2373538 A1 FR 2373538A1 FR 7736892 A FR7736892 A FR 7736892A FR 7736892 A FR7736892 A FR 7736892A FR 2373538 A1 FR2373538 A1 FR 2373538A1
Authority
FR
France
Prior art keywords
new
preparation process
product containing
medicinal product
prostane derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7736892A
Other languages
English (en)
French (fr)
Other versions
FR2373538B1 (en:Method
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of FR2373538A1 publication Critical patent/FR2373538A1/fr
Application granted granted Critical
Publication of FR2373538B1 publication Critical patent/FR2373538B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/08Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/06Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D331/00Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04Four-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Steroid Compounds (AREA)
FR7736892A 1976-12-08 1977-12-07 Nouveaux derives de prostane, leur procede de preparation et medicament les contenant Granted FR2373538A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51196/76A GB1550399A (en) 1976-12-08 1976-12-08 Prostane derivatives

Publications (2)

Publication Number Publication Date
FR2373538A1 true FR2373538A1 (fr) 1978-07-07
FR2373538B1 FR2373538B1 (en:Method) 1981-07-10

Family

ID=10459023

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7736892A Granted FR2373538A1 (fr) 1976-12-08 1977-12-07 Nouveaux derives de prostane, leur procede de preparation et medicament les contenant

Country Status (14)

Country Link
JP (1) JPS5371060A (en:Method)
AU (1) AU3104477A (en:Method)
BE (1) BE861652A (en:Method)
CA (1) CA1119591A (en:Method)
DE (1) DE2754741A1 (en:Method)
DK (1) DK548177A (en:Method)
FR (1) FR2373538A1 (en:Method)
GB (1) GB1550399A (en:Method)
IE (1) IE46170B1 (en:Method)
IT (1) IT1089433B (en:Method)
NL (1) NL7713587A (en:Method)
NZ (1) NZ185822A (en:Method)
SE (1) SE7713895L (en:Method)
ZA (1) ZA777059B (en:Method)

Also Published As

Publication number Publication date
AU3104477A (en) 1979-06-07
ZA777059B (en) 1978-08-30
FR2373538B1 (en:Method) 1981-07-10
CA1119591A (en) 1982-03-09
JPS5371060A (en) 1978-06-24
BE861652A (fr) 1978-06-08
IE46170B1 (en) 1983-03-09
SE7713895L (sv) 1978-06-09
NL7713587A (nl) 1978-06-12
DK548177A (da) 1978-06-09
DE2754741A1 (de) 1978-06-15
IE46170L (en) 1978-06-08
NZ185822A (en) 1979-03-16
GB1550399A (en) 1979-08-15
IT1089433B (it) 1985-06-18

Similar Documents

Publication Publication Date Title
FR2370723A1 (fr) Nouveaux aryl-acylamides n-(2-aminocycloaliphatiques), leur procede de preparation et medicament les contenant
FR2378763A1 (fr) Nouveaux derives de 1,4-dihydropyridine substitues en position 2, leur procede de preparation et medicament les contenant
FR2370722A1 (fr) Nouveaux benzamides trans-n-(2-aminocycloaliphatiques), leur procede de preparation et medicament les contenant
OA04910A (fr) Procédé de préparation de nouveaux dérivés d'acide oxy-16 prostanoïque.
FR2362833A1 (fr) Nouveaux derives 5 de prostaglandine, leur procede de preparation et medicament les contenant
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
FR2416889A1 (fr) Derives esters de l'acide dihydro-1,4-pyridine-dicarboxylique-3,5, medicaments a base de ces derives et leur procede de production
DZ473A1 (fr) Dérivés de l'acide cis-endo-2-azabicyclo/3,3,o/-octane-3-carboxylique, procédé pour leur préparation, agents contenant ces dérivés et leur utilisation.
FR2426681A1 (fr) Derives d'hydantoine, procede pour leur preparation et application de ces composes comme medicaments
FR2328460A1 (fr) Acide 3-trihydroxygermyl-propionique et ses sels, procede pour les preparer et medicaments contenant ces nouveaux composes
FR2435479A1 (fr) Procede de preparation de composes d'acide 3-cephem-4-carboxylique 3, 7-disubstitue et de leurs sels pharmaceutiquement acceptables, nouveaux produits ainsi obtenus et leur utilisation pour leurs activites antimicrobiennes
FR2361877A1 (fr) Nouvelles lactones d'acides libres du type prostaglandine, leur preparation et medicament les contenant
FR2370744A1 (fr) Nouveaux derives d'aminopropanol, procede pour leur preparation et medicaments contenant ces composes
FR2403330A1 (fr) Nouveaux derives de benzoyl-2-chloro-4-glycinanilides substitues, leur procede de preparation et leur application en tant que medicaments
FR2375222A1 (fr) Nouveaux composes du type (2-benzothiazolyl)oxamate, leur procede de preparation et medicament les contenant
FR2367055A1 (fr) Nouveaux derives d'alcanolamines, leur procede de preparation et composition pharmaceutique les contenant
FR2395272A1 (fr) Nouveaux medicaments derives de l'acide amidinopenicillanique
FR2362841A1 (fr) Derives d'acides heterocyclyl-carboxyliques acyles utiles comme medicaments et procede pour leur preparation
FR2390424A1 (fr) Nouveaux derives d'amides de l'acide phenylacetique substitues, leur application en tant que medicament et leur application
FR2373538A1 (fr) Nouveaux derives de prostane, leur procede de preparation et medicament les contenant
FR2401139A2 (fr) Nouveaux derives d5 de prostaglandines, leur procede de preparation et medicaments les contenant
FR2392028A1 (fr) Nouveaux composes heterocycliques, leur procede de preparation et medicament les contenant
FR2367065A1 (fr) Nouveaux composes du type 1-amino-2-hydroxy-3-heterocyclyloxy-propane utiles en tant que medicaments et leur procede de preparation
FR2408589A1 (fr) Nouvelles 13,14-bisdeshydroprostaglandines, leur procede de preparation et leurs applications therapeutiques
FR2355839A1 (fr) Derives optiquement actifs d'acide benzoxazolyl-propionique, procede pour leur preparation et compositions therapeutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse